Rectal Cancer Treatment (PDQ®) - NCI
Relapsed/Refractory Aggressive Non Hodgkins Lymphoma - CancerConnect
Do older patients (> 80 years) also benefit from ERAS after
Gabriele BISLENGHI, Universitair Ziekenhuis Leuven, Leuven
Illustrations describing specific procedures of three groups. In the
Does Pathological Complete Response after Neoadjuvant Therapy Influence Postoperative Morbidity in Rectal Cancer after Transanal Total Mesorectal Excision?
Albert Wolthuis's research works Universitair Ziekenhuis Leuven
Nele BOON, Research Statistics manager, PhD
Frontiers Sexual Dimorphism in Colon Cancer
Frontiers Risk Factors for High-Risk Adenoma on the First Lifetime Colonoscopy Using Decision Tree Method: A Cross-Sectional Study in 6,047 Asymptomatic Koreans
Frontiers Herbal medicine and its impact on the gut microbiota in colorectal cancer
Cancers, Free Full-Text